Table 4.

NIH funding opportunity announcements

Funding opportunity announcement	Number	Link
PPQ‐6: How can mouse or other preclinical models be used to study how standard of care and investigational therapies affect normal tissue and lead to adverse events later in life?	PAR‐16‐217	Research Answers to NCI’s Pediatric Provocative Questions (R21) https://grants.nih.gov/grants/guide/pa-files/PAR-16-217.html
PPQ‐7: How can prediction models be developed and used to identify patients at highest risk of treatment‐related complications?	PAR‐16‐218	NCI Research Answers to NCI’s Pediatric Provocative Questions (R01) https://grants.nih.gov/grants/guide/pa-files/PAR-16-218.html
National Cancer Institute (NCI) Mechanisms of Cancer and Treatment‐related Symptoms and Toxicities (R21)	PA‐16‐258	https://grants.nih.gov/grants/guide/pa-files/PA-16-258.html
National Institutes of Health (NIH) Serious Adverse Drug Reaction Research (R01/R21)	PAR‐16‐275 and PAR‐16‐274	https://grants.nih.gov/grants/guide/pa-files/PAR-16-275.html and https://grants.nih.gov/grants/guide/pa-files/PAR-16-274.html